Projects per year
Abstract
Cancer stem cells (CSCs) have been implicated in cancer recurrence and therapy resistance. Therefore,a CSC-targeted therapy that disrupts the maintenance and survival of CSCs may offer an effectiveapproach in killing tumor cells in primary tumors and preventing the metastasis caused by CSCs.Nanoparticles (NPs)-based thermotherapy and/or chemotherapy are promising therapeutic methods forcancer treatment.
Methods: A silica-based multifunctional NP system was present, which encapsulated achemotherapeutic agent and magnetic cores and coated with a specific antibody against the lung CSCs.The efficacy of this novel therapeutic strategy was systematically studied both in vitro and in vivo bysimultaneous activating the combined thermotherapy and chemotherapy via CSC-targeted NPs.
Results: These NPs were systematically administered and activated for targeted chemotherapy andthermotherapy by using an externally applied alternating magnetic field (AMF). The antibody-modifiedNPs targeted to lung CSCs with enhanced cellular uptake in vitro and extended accumulation in tumor invivo. Up to 98% of lung CSCs was killed in vitro with 30-min application of AMF, due to the combinedeffects of hyperthermia and chemotherapeutic drug treatment. In in vivo models, this combined therapysignificantly suppressed tumor growth and metastasis in lung CSC xenograft-bearing mice, with minimalside effects and adverse effects.
Conclusion: With good biocompatibility and targeting capability, the nanodrug delivery system mayoffer a promising clinical platform for the combined thermotherapy and chemotherapy. This workdemonstrated the feasibility of developing multifunctional nanomedicine targeting CSCs for effectivecancer treatment.
Methods: A silica-based multifunctional NP system was present, which encapsulated achemotherapeutic agent and magnetic cores and coated with a specific antibody against the lung CSCs.The efficacy of this novel therapeutic strategy was systematically studied both in vitro and in vivo bysimultaneous activating the combined thermotherapy and chemotherapy via CSC-targeted NPs.
Results: These NPs were systematically administered and activated for targeted chemotherapy andthermotherapy by using an externally applied alternating magnetic field (AMF). The antibody-modifiedNPs targeted to lung CSCs with enhanced cellular uptake in vitro and extended accumulation in tumor invivo. Up to 98% of lung CSCs was killed in vitro with 30-min application of AMF, due to the combinedeffects of hyperthermia and chemotherapeutic drug treatment. In in vivo models, this combined therapysignificantly suppressed tumor growth and metastasis in lung CSC xenograft-bearing mice, with minimalside effects and adverse effects.
Conclusion: With good biocompatibility and targeting capability, the nanodrug delivery system mayoffer a promising clinical platform for the combined thermotherapy and chemotherapy. This workdemonstrated the feasibility of developing multifunctional nanomedicine targeting CSCs for effectivecancer treatment.
Original language | English |
---|---|
Pages (from-to) | 1181-1197 |
Journal | Theranostics |
Volume | 10 |
Issue number | 3 |
Online published | 1 Jan 2020 |
DOIs | |
Publication status | Published - Feb 2020 |
Research Keywords
- Lung cancer stem cell
- Multifunctional nanoparticle
- Alternating magnetic field
- Thermotherapy and chemotherapy
- TUMOR-CELLS
- RESISTANCE
- DELIVERY
- AXIS
- DIFFERENTIATION
- ACTIVATION
- PATHWAYS
- HEDGEHOG
Publisher's Copyright Statement
- This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/
Fingerprint
Dive into the research topics of 'Targeted destruction of cancer stem cells using multifunctional magnetic nanoparticles that enable combined hyperthermia and chemotherapy'. Together they form a unique fingerprint.Projects
- 2 Finished
-
GRF: Quantitative Study of Cancer Stem Cells Growth, Migration and Communication with Cancer Cells in a Microfluidic-based Biomimetic Microenvironment
YANG, M. (Principal Investigator / Project Coordinator), AU, S. K. J. (Co-Investigator) & GUAN, X. Y. (Co-Investigator)
1/01/16 → 19/12/19
Project: Research
-
ITF: Development of Anti-cancer Therapy with Externally Activated Nanomedicine
YANG, M. (Principal Investigator / Project Coordinator), AU, J. S. K. (Co-Investigator) & YIP, T.-C. T. (Co-Investigator)
1/12/14 → 30/04/17
Project: Research